Caglar Meltem, Tuncel Murat, Usubutun Alp
Hacettepe University Medical Faculty, Department of Nuclear Medicine, Ankara, Turkey.
Clin Nucl Med. 2003 Nov;28(11):945-6. doi: 10.1097/01.rlu.0000093316.56231.91.
Whole-body I-131 scintigraphy is an important component of the postoperative follow-up of patients with well-differentiated thyroid cancer. However, false-positive scans showing abnormal uptake in the absence of residual thyroid tissue or metastases may occur. Unless recognized as false positive, these abnormal sites of uptake may lead to unnecessary administration of therapeutic doses of I-131. The authors report a patient with Warthin tumor whose I-131 whole-body scan demonstrated increased uptake in the parotid gland, despite a negative Tc-99m pertechnetate salivary gland scintigraphy.
全身碘-131闪烁扫描是分化型甲状腺癌患者术后随访的重要组成部分。然而,可能会出现假阳性扫描结果,即在没有残留甲状腺组织或转移灶的情况下显示异常摄取。除非被识别为假阳性,这些异常摄取部位可能导致不必要地给予治疗剂量的碘-131。作者报告了一名患有沃辛瘤的患者,其碘-131全身扫描显示腮腺摄取增加,尽管锝-99m高锝酸盐唾液腺闪烁扫描结果为阴性。